Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Moneyhero | MNY | Mar 11, 2025 | 0.79 | -4.82 |
MoneyLion A | ML | Mar 11, 2025 | 87.10 | 0.00 |
MongoDB A | MDB | Mar 11, 2025 | 195.70 | +8.53 |
Monogram Technologies | MGRM | Mar 11, 2025 | 2.27 | +1.34 |
Monolithic Power Systems | MPWR | Mar 11, 2025 | 570.35 | -1.93 |
Monopar Therapeutics | MNPR | Mar 11, 2025 | 29.28 | +4.76 |
Monro | MNRO | Mar 11, 2025 | 16.48 | -3.63 |
Monroe Capital | MRCC | Mar 11, 2025 | 8.09 | -0.61 |
Monster Beverage | MNST | Mar 11, 2025 | 55.23 | -0.97 |
Montauk Renewables | MNTK | Mar 11, 2025 | 2.77 | -1.77 |
Monte Rosa Therapeutics | GLUE | Mar 11, 2025 | 6.11 | +1.33 |
Montrose Environmental Group | MEG | Mar 11, 2025 | 17.59 | +6.35 |
Moodys | MCO | Mar 11, 2025 | 443.85 | -1.43 |
Moog A | MOG-A | Mar 11, 2025 | 173.06 | +1.54 |
Moog B | MOG-B | Mar 11, 2025 | 172.17 | +2.53 |
Moolec Science | MLEC | Mar 11, 2025 | 0.94 | +11.24 |
MoonLake Immunotherapeutics | MLTX | Mar 11, 2025 | 37.74 | +2.69 |
Morgan Stanley | MS | Mar 11, 2025 | 112.04 | +0.31 |
Morgan Stanley China A Share Fund | CAF | Mar 11, 2025 | 12.87 | +1.10 |
Morgan Stanley Direct Lending Fund | MSDL | Mar 11, 2025 | 20.08 | -0.35 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Mar 11, 2025 | 8.08 | +0.25 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Mar 11, 2025 | 4.76 | +0.42 |
Morgan Stanley FXDFR Pref | MS-K | Mar 11, 2025 | 24.60 | -0.40 |
Morgan Stanley India Investment Fund | IIF | Mar 11, 2025 | 23.19 | +0.65 |
Morgan Stanley Pref A | MS-A | Mar 11, 2025 | 23.49 | +0.13 |
Morgan Stanley Pref E | MS-E | Mar 11, 2025 | 25.58 | -0.10 |
Morgan Stanley Pref F | MS-F | Mar 11, 2025 | 25.37 | +0.08 |
Morgan Stanley Pref I | MS-I | Mar 11, 2025 | 25.26 | 0.00 |
Morgan Stanley Pref L | MS-L | Mar 11, 2025 | 20.75 | -0.67 |
Morgan Stanley Pref O | MS-O | Mar 11, 2025 | 18.43 | -0.38 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.